With events unfolding at speed in this crisis, proactivity and planning are favorable over last minute changes to keep disruptions at bay.
Annual meeting highlights progress on the company’s transformation and growth strategy.
Novartis researchers aim to preserve kidney function – and quality of life – for patients.
Novartis researchers are using data to accelerate drug development.
Five virtual power purchase agreements with three developers expected to add more than 275 megawatts of clean power to the electrical grid.
These stories offer a glimpse into the lives of people touched by a new era of medicine.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.